Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.79%
#4 aPriori aPriori +183.92%
#5 Bedrock Bedrock +80.53%
#6 Cysic Cysic +51.82%
#7 Prom Prom +45.70%
#8 Playnance Playnance +34.93%
#9 Bitway Bitway +27.53%
#10 COTI COTI +26.22%
Coin of the day
Wrapped One Wrapped One
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Hisse Senetlerindeki Sıralama #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Hisse Fiyatı
$0.00023723
Son senkronizasyon: 2024-08-26
Piyasa Değeri
$1.41K
Değişim (1 gün)
111.67%
Değişim (1 yıl)
0.00%
Ülke
FR
Ticaret Pharnext S.A. (ALPHA)

Kategori

Healthcare
Pharnext S.A. (ALPHA) için gelir
Dec 2023 itibarıyla gelir TTM: $-487.61K
Pharnext S.A. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $-487.61K'dir. 2022 yılında şirketin geliri $598.55 önceki yıla göre azalma 2021 yılındaki $96.41K gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Pharnext S.A. için 2013 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
2026 (TTM) $-487.61K -4,510.88%
2023 $11.05K 1,746.90%
2022 $598.55 -99.38%
2021 $96.41K 98.76%
2020 $48.51K -82.90%
2019 $283.61K -96.39%
2018 $7.85M 96.92%
2017 $3.99M -14.33%
2016 $4.65M 62.80%
2015 $2.86M -14.35%
2014 $3.34M -7.92%
2013 $3.62M 0.00%
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -2,589,130.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -1,234,964.32%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -2,073,651.57%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR